Cited by 477BRCA gene mutations in cancerBreast Lesions and CarcinomasDNA Repair Mechanisms

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Ten Genes for Inherited Breast Cancer

Open access

Walsh, Tom, King, Mary-Claire·2007·Cancer Cell

DOI 10.1016/j.ccr.2007.01.010

Open this paper in CoChat — free account Open PDF

Abstract

Inherited breast cancer is associated with germline mutations in ten different genes in pathways critical to genomic integrity. BRCA1 and BRCA2 mutations confer very high risks of breast and ovarian cancer. p53 and PTEN mutations lead to very high breast cancer risks associated with rare cancer syndromes. Mutations in CHEK2, ATM, NBS1, RAD50, BRIP1, and PALB2 are associated with doubling of breast cancer risks. In addition, biallelic mutations in BRCA2, BRIP1, and PALB2 cause Fanconi anemia. The convergence of these genes in a shared role reveals underlying biology of these illnesses and suggests still other breast cancer genes.

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2007.01.010

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Biallelic Inactivation of BRCA2 in Fanconi Anemia
Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
The CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Rahman, N., Seal, S., Thompson, D. J., Kelly, P. F., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., Chagtai, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1959 · Cited by 1,026
Essential role for nuclear PTEN in maintaining chromosomal integrity
Shen, W. H., Balajee, A. S., Wang, J., Wu, H., Eng, C., Pandolfi, P. P., & Yin, Y. (2007) · Cell · doi:10.1016/j.cell.2006.11.042 · Cited by 979
Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2
Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., Couch, F. J., & Livingston, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.022 · Cited by 861
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles
Renwick, A., Thompson, D. J., Seal, S., Kelly, P. F., Chagtai, T., Ahmed, M., North, B. V., Jayatilake, H., Barfoot, R., Spanova, K., et al. (2006) · Nature Genetics · doi:10.1038/ng1837 · Cited by 770
Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles
The Breast Cancer Susceptibility Collaboration (UK), Seal, S., Thompson, D., Renwick, A., Elliott, A., Kelly, P., Barfoot, R., Chagtai, T., Jayatilake, H., Ahmed, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1902 · Cited by 746
Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer
Walsh, T., Casadei, S., Coats, K. H., Swisher, E. M., Stray, S. M., Higgins, J., Roach, K. C., Mandell, J. B., Lee, M. K., Čierniková, S., et al. (2006) · JAMA · doi:10.1001/jama.295.12.1379 · Cited by 673
Self-citation
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Reid, S., Schindler, D., Hanenberg, H., Barker, K., Hanks, S., Kalb, R., Neveling, K., Kelly, P., Seal, S., Freund, M., et al. (2007) · Nature Genetics · doi:10.1038/ng1947 · Cited by 642
A recurrent mutation in PALB2 in Finnish cancer families
Erkko, H., Xia, B., Nikkilä, J., Schleutker, J., Syrjäkoski, K., Mannermaa, A., Kallioniemi, A. H., Pylkäs, K., Karppinen, S., Rapakko, K., et al. (2007) · Nature · doi:10.1038/nature05609 · Cited by 471

Flagged first, then by citations

Show all 15 references

Research works printed but not linked: 4

Erkko, 2007, Nature
Rahman, 2006, Nat. Genet.
Reid, 2006, Nat. Genet.
Xia, 2006, Nat. Genet.

Sorted by citations

Items 301–400 of 469

Genetic Variation of The BRCA1 and BRCA2 Genes in Macedonian Patients
Plaseska‐Karanfilska, D., Kostovska, I. M., Madjunkova, S., Bozhinovski, G., Smickova, E., Кондов, Г., Spiroski, Z., & Arsovski, A. (2012) · Balkan Journal of Medical Genetics · doi:10.2478/v10034-012-0025-8 · Cited by 8
Breast Cancer Prevention
Thompson, P. A., Laukaitis, C. M., & Stopeck, A. (2013) · Springer eBooks · doi:10.1007/978-3-642-38983-2_15 · Cited by 8
siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/− with susceptibility versus C57BL/6-Trp53+/− mice with resistance to mammary tumors
Böhringer, M., Obermeier, K., Griner, N. B., Waldraff, D., Dickinson, E. S., Eirich, K., Schindler, D., Hagen, M. J., Jerry, D. J., & Wiesmüller, L. (2013) · Oncogene · doi:10.1038/onc.2013.38 · Cited by 8
MICA‐129 Met/Val polymorphism could be a genetic biomarker for Familial Breast Cancer in the Tunisian population
Ouni, N., Chaaben, A. B., Ayari, F., Douik, H., Guizani, I., Elgaaïed, A. B. A., Guémira, F., & Tamouza, R. (2020) · International Journal of Immunogenetics · doi:10.1111/iji.12480 · Cited by 9
Genetic and epigenetic alterations in night shift nurses with breast cancer: a narrative review
Li, X., Hu, Y., & Aslanbeigi, F. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03649-6 · Cited by 7
Detecting Association of Rare Variants by Testing an Optimally Weighted Combination of Variants for Quantitative Traits in General Families
Fang, S., Zhang, S., & Sha, Q. (2013) · Annals of Human Genetics · doi:10.1111/ahg.12038 · Cited by 7
Germline Mutations in Cancer Susceptibility Genes: An Overview for Nurses
MacDonald, D. J. (2011) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2010.11.004 · Cited by 7
Functional analysis—Make or break for cancer predictability
Deniz, M., Holzmann, K., & Wiesmüller, L. (2013) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2013.03.009 · Cited by 7
Design and synthesis of BRC analogous peptides and their interactions with a key p53 peptide
Zhao, D., Lü, K., Liu, G., Ma, L., Zhu, H., & He, J. (2018) · FEBS Letters · doi:10.1002/1873-3468.13256 · Cited by 7
Four common polymorphisms of BRIP1 (rs2048718, rs4988344, rs4986764, and rs6504074) and cancer risk: evidence from 13,716 cancer patients and 15,590 cancer-free controls
Liu, D., Zheng, Y., Wang, M., Deng, Y., Lin, S., Zhou, L., Yang, P., Dai, C., Xu, P., Hao, Q., et al. (2018) · Aging · doi:10.18632/aging.101388 · Cited by 7
Hereditary predisposition to breast cancer – with a focus on AATF , MRG15 , PALB2 , and three Fanconi anaemia genes
Haanpää, M. K. (2014) · Cited by 6
CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival
Minguillón, J., Ramı́rez, M. J., Rovirosa, L., Bustamante‐Madrid, P., Camps-Fajol, C., Ponce, G. R. D. G., Shimelis, H., Montanuy, H., Pujol, R. M., Hernández, G., et al. (2022) · Cancers · doi:10.3390/cancers14020353 · Cited by 6
Breast Cancer Susceptibility Genes
Wiesmüller, L. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_6619 · Cited by 6
Prognostic and predictive factors of invasive ductal breast carcinomas.
Lialiaris, T. S., Georgiou, G. K., Sivridis, E., Kareli, D., Tripsiannis, G. A., Papageorgiou, A., Chrisafi, S., Kritsi, Z. I. , & Giatromanolaki, A. N. (2010) · PubMed · Cited by 5
Breast and ovarian cancer referrals to the ACT Genetic Service: are we meeting guidelines?
Aitken, L., Warwick, L., & Davis, A. J. (2016) · Internal Medicine Journal · doi:10.1111/imj.13357 · Cited by 5
Familial Breast Cancer - Targeted Therapy in Secondary and Tertiary Prevention
Kast, K., & Rhiem, K. (2015) · Breast Care · doi:10.1159/000380756 · Cited by 5
Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: A proof of principle study
Bubien, V., Bonnet, F., Dupiot-Chiron, J., Barouk-Simonet, E., Jones, N. B., de Reyniès, A., MacGrogan, G. M., Sévenet, N., Letouzé, É., & Longy, M. (2017) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22482 · Cited by 5
Familial breast cancer: recent advances
Slijepčević, P. (2007) · Acta Medica Academica · Cited by 5
Fluorescence-Based Quantification of Pathway-Specific DNA Double-Strand Break Repair Activities: A Powerful Method for the Analysis of Genome Destabilizing Mechanisms
Böhringer, M., & Wiesmüller, L. (2009) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-90-481-3471-7_15 · Cited by 5
Genetic Issues in Patients with Breast Cancer
Fossland, V. S., Stroop, J., Schwartz, R. C., & Kurtzman, S. H. (2008) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2008.08.008 · Cited by 5
Cancer of the Breast and Female Reproductive Tract
Gordon, O. K. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00093-8 · Cited by 5
The prognostic role of matrix metalloproteinases MMP-2 and -9 and their tissue inhibitors TIMP-1 and -2 in primary breast carcinoma
Kuvaja, P. (2007) · Cited by 5
Epigenetic regulation of BRCA1 expression and its role inbreast cancer stem cell development
Shestakova, E. A. (2016) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1507-145 · Cited by 4
TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study
Blaut, M. A., Bogdanova, N. V., Bremer, M., Karstens, J. H., Hillemanns, P., & Dörk, T. (2010) · Journal of Negative Results in BioMedicine · doi:10.1186/1477-5751-9-9 · Cited by 4
Genetic Features of Tumours Arising in the Context of Suspected Hereditary Cancer Syndromes with RAD50, RAD51C/D, and BRIP1 Germline Mutations, Results of NGS-Reanalysis of BRCA/MMR-Negative Families
Arranz-Ledo, M., Infante, M., Lastra, E., Olaverri, A., Orozco, M., Mateo, L. C., Martínez, N., Hernández, L., & Durán, M. (2025) · Genes · doi:10.3390/genes16040458 · Cited by 4
Meta-Analysis of Association between PALB2 Polymorphisms and Breast Cancer
Dianatpour, A., Faramarzi, S., & Ghafouri‐Fard, S. (2018) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2018.19.10.2897 · Cited by 4
Two tSNPs in BRIP1 are associated with breast cancer during TDT analysis
Li, X., Li, Z., Yang, M., Luo, Y., Hu, L., Xiao, Z. Q., Huang, A., & Huang, J. (2021) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1578 · Cited by 4
Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment
Torossian, N., Gabriel, M., Papoutsoglou, P., Foretek, D., Brochard, C., Kamal, M. T., Ramdani, L., Lamy, C., Lecerf, C., Halladjian, M., et al. (2025) · NAR Cancer · doi:10.1093/narcan/zcaf036 · Cited by 3
Detecting association of rare and common variants by adaptive combination of P-values
Zhou, Y.-J., & Wang, Y. (2015) · Genetics Research · doi:10.1017/s0016672315000208 · Cited by 3
Breast cancer metastatic dormancy and emergence, a role for adjuvant statin therapy
Beckwitt, C. H. (2018) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 3
RAD50 Loss of Function Variants in the Zinc Hook Domain Associated with Higher Risk of Familial Esophageal Squamous Cell Carcinoma
Ko, J. M. Y., Lam, S. Y., Ning, L., Chai, A. W. Y., Lei, L. C., Choi, S. S. A., Wong, C. W.-Y., & Lung, M. L. (2021) · Cancers · doi:10.3390/cancers13184715 · Cited by 3
Hereditary breast cancer
Haddad, C. F. (2020) · Mastology · doi:10.29289/25945394202020200042 · Cited by 3
Study of Single Nucleotide Polymorphisms Associated with Breast Cancer Patients among Arab Ancestries
Osman, Y., Elsharkawy, T., Hashim, T. M., Alratroot, J. A., Aljindan, F., Almulla, L., Alsuwat, H. S., Otaibi, W. M. A., Hegazi, F. M., Ibrahim, A. M., et al. (2022) · International Journal of Breast Cancer · doi:10.1155/2022/2442109 · Cited by 3
Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers
Elsakov, P., Foretová, L., Goetz, P., de Groot, J. W. B., van der Graaf, W. T. A., Guler, G., Huebner, K., Kingsbury, N., Hamann, U., Ho, J. W. C., et al. (2007) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-5-3-119 · Cited by 3
Design, synthesis and interaction of BRC4 analogous peptides with RAD51(241–260)
Li, J., Lü, K., Lv, M., Liu, G., Ma, L., & Qi, J. (2019) · Amino Acids · doi:10.1007/s00726-019-02813-3 · Cited by 3
Dose‐dependent effects of aerobic exercise on clinically relevant biomarkers among healthy women at high genetic risk for breast cancer: A secondary analysis of a randomized controlled study
Ehret, C. J., Zhou, S., Tchou, J. C., Schmitz, K. H., & Sturgeon, K. M. (2021) · Cancer Reports · doi:10.1002/cnr2.1497 · Cited by 3
Frequency of germline genetic variants in women with a personal or family history of breast cancer from Brazil
Pereira, J. Z., Carneiro, J. G., Vieira, M. S., Valente, B. M., de Oliveira, P. Z., Mello, C. L., de Campos, C. L. V., & Gomes, K. B. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07840-0 · Cited by 3
Erblicher Brust- und Eierstockkrebs
Gadzicki, D., Meindl, A., & Schlegelberger, B. (2007) · Medizinische Genetik · doi:10.1007/s11825-007-0019-1 · Cited by 3
Genetics of breast cancer: Contribution of BRCA1/2 genes alterations to hereditary predisposition
Brankovic-Magic, M. V., Dobričić, J., & Krivokuća, A. (2012) · Vojnosanitetski pregled · doi:10.2298/vsp110421014b · Cited by 3
Cancer of the Breast
Wolff, A. C., Domchek, S. M., Davidson, N. E., Sacchini, V., & McCormick, B. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00091-6 · Cited by 6
New Biomarkers in Breast Cancer: microRNAs and Leptins – Where Are We Now?
Keith, T., Amber, V., & Stebbing, J. (2007) · Biomarkers in Medicine · doi:10.2217/17520363.1.1.9 · Cited by 3
Biochemical markers and genetic risk factors in canine tumors
Rivera, P. (2010) · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences)) · Cited by 3
Family history and risk assessment in black South African women with breast cancer
Wainstein, T. (2012) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 3
Breast Cancer Susceptibility Genes
Deniz, M., & Wiesmüller, L. (2017) · Springer eBooks · doi:10.1007/978-3-662-46875-3_6619 · Cited by 3
High familial risks in some rare cancers may pinpoint to hidden germline genetics: focus on esophageal, stomach, small intestinal, testis, thyroid and bone cancers
Hemminki, K., Hemminki, O., Koskinen, A. I. M., Hemminki, A., & Försti, A. (2025) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-024-00303-6 · Cited by 2
Improving genetic diagnosis of hereditary tumor syndromes: From expanded gene panels to functional genomics
Sauer, M., Lucas, M. C., Prokosch, V., Keßler, T., Risch, T., Laner, A., Henkel, J., Benet‐Pagès, A., Hallermayr, A., Steinke‐Lange, V., et al. (2025) · International Journal of Cancer · doi:10.1002/ijc.70274 · Cited by 2
The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells
Datta, A., Jackson, J., Morozov, Y. I., Qiu, J., Vindigni, A., & Greenberg, R. A. (2026) · Nature Communications · doi:10.1038/s41467-026-75271-7 · Cited by 2
Addressing inherited predisposition for breast cancer in transplant recipients
Yang, R. L., Kurian, A. W., Winton, L. M., Weill, D., Patel, K., Kingham, K. E., & Wapnir, I. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24193 · Cited by 2
Importance of multigene panel test in patients with consanguineous marriage and family history of breast cancer
Özmen, V., Çağlayan, A. O., Yararbaş, K., Ordu, Ç., Aktepe, F., Özmen, T., İlgün, A. S., Soybir, G., Alço, G., Tsaousis, G., et al. (2022) · Oncology Letters · doi:10.3892/ol.2022.13238 · Cited by 2
Immunohistochemical study of CD74 biomarker in normal and malignant breast tissues
Hassan, H. N., Al-Hussein, R. K. A., & Al-Naqeeb, A. (2024) · Polski Merkuriusz Lekarski · doi:10.36740/merkur202402113 · Cited by 2
Evaluation of common breast complaints in primary care
Smania, M. A. (2017) · The Nurse Practitioner · doi:10.1097/01.npr.0000524661.93974.e8 · Cited by 2
Breast Cancer Prevention
Thompson, P. A., Preece, C., & Stopeck, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-15935-1_16 · Cited by 2
Detecting association with rare variants for common diseases using haplotype-based methods
Feng, T., Li, Y., & Zhu, X. (2011) · Statistics and Its Interface · doi:10.4310/sii.2011.v4.n3.a2 · Cited by 2
The Fanconi Anemia Pathway and Interstrand Cross-Link Repair
Ishiai, M., Tomida, J., Itaya, A., Hejna, J., & Takata, M. (2016) · Springer eBooks · doi:10.1007/978-4-431-55873-6_8 · Cited by 2
Cancer Genetics at a Glance: The Comprehensive Insights
Azarnezhad, A., & Mehdipour, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-64550-6_5 · Cited by 2
Association analysis of multiple traits by an approach of combining $$P$$ P values
Chen, L., Wang, Y., & Zhou, Y. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0885-0 · Cited by 2
Breast Cancer And Exposure to Hazardous Contaminants: A Minefield of Feats and Challenges
Villa-Guillen, D. E. (2020) · Open Access Journal of Biomedical Science · doi:10.38125/oajbs.000169 · Cited by 2
Next-Generation Sequencing for Cancer Biomarker Discovery
Desai, A. N., & Jere, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-15811-2_7 · Cited by 2
Is RAD51 135G>C polymorphism really associated with breast cancer in general population? Biased design and results lead to inappropriate conclusion
Yu, K.-D., Li, B., Zhou, Y., & Shao, Z. M. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1402-9 · Cited by 2
Genetic Markers in Breast Tumors with Hereditary Predisposition
Grushko, T. A., & Olopade, O. I. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-470-4_4 · Cited by 2
Genetics of equine insect bite hypersensitivity and genetic diversity in horses
Shrestha, M. (2017) · doi:10.18174/396810 · Cited by 2
Molecular Mechanisms of Early Breast Cancer
Ariyannur, P. S., & Srinivasalu, V. K. (2020) · Springer eBooks · doi:10.1007/978-981-15-6171-9_5 · Cited by 1
A two-stage testing strategy for detecting genes×environment interactions in association studies
Zhou, J., Li, S., Zhou, Y., & Sheng, X. (2021) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkab220 · Cited by 1
MDIG in Breast Cancer Progression and Metastasis
Thakur, C., Qiu, Y., Bi, Z., Wang, Z., & Fei, C. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-66686-5_1 · Cited by 1
Occurrence of Malignancies Other than Breast and Ovarian Cancer in Female Carriers of a BRCA1/2 Germline Pathogenic Variant
Stuursma, A., van der Vegt, B., Berger, L. P. V., ten Hoor, M. B. C., Oosterwijk, J. C., Mourits, M. J. E., & de Bock, G. H. (2025) · Cancers · doi:10.3390/cancers17101687 · Cited by 1
The Importance of ERα/ERβ Ratio in Breast Cancer: Mitochondrial Function and Oxidative Stress
Roca, P., Oliver, J., Sastre‐Serra, J., & Nadal‐Serrano, M. (2011) · InTech eBooks · doi:10.5772/21807 · Cited by 1
Homologous Recombination in Mammals
Barascu, A., Grabarz, A., & López, B. S. (2012) · Topics in current genetics · doi:10.1007/978-94-007-4531-5_4 · Cited by 1
The Molecular Biology of Breast Cancer
Lee, A. V., Oesterreich, S., & Davidson, N. E. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00036-6 · Cited by 1
A gene based approach to test genetic association based on an optimally weighted combination of multiple traits
Zhang, J., Sha, Q., Liu, G., & Wang, X. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220914 · Cited by 1
Improving the accuracy and internal consistency of regression-based clustering of high-dimensional datasets
Zhang, B., He, J., Hu, J., Chalise, P., & Koestler, D. C. (2023) · Statistical Applications in Genetics and Molecular Biology · doi:10.1515/sagmb-2022-0031 · Cited by 1
Carrying SNP rs17506395 (T > G) in TP63 gene and CCR5Δ32 mutation associated with the occurrence of breast cancer in Burkina Faso
Traoré, L., Savadogo, M., Zouré, A. A., Kiendrebeogo, I. T., Soudre, F. M., Dabré, S., Traoré, A. D. D., Adico, M. D. W., Lare, T., Ouedraogo, T. C., et al. (2024) · Open Life Sciences · doi:10.1515/biol-2022-0847 · Cited by 1
Perceptions of Breast Cancer-Related Stigma and Genetic Knowledge Among Latina Women: El Mejor Entendimiento Del Miedo.
Cognetti, J. M. (2013) · Scholar Commons (University of South Carolina) · Cited by 1
Regulation of BACH1/FANCJ Function in DNA Damage Repair: A Dissertation
Xie, J. (2009) · eScholarship@UMassChan · doi:10.13028/95cm-wn54 · Cited by 1
Genetics of breast cancer: applications to the Mexican population.
Ziv, E. (2011) · PubMed · Cited by 1
Implication of the Strand-Specific Imprinting and Segregation Model: Integrating in utero Hormone Exposure, Stem Cell and Lateral Asymmetry Hypotheses in Breast Cancer Aetiology
Lazzara, S. H. C. A. (2012) · Hereditary Genetics · doi:10.4172/2161-1041.s2-005 · Cited by 1
Cells of patients with Down syndrome—a model to study mechanisms of oncogenesis and hypersensitivity to genotoxicants and antimutagenesis
Засухина, Г. Д., Vf, M., Vasilyeva, I. M., & Шуленина, Л. В. (2016) · Biology Bulletin Reviews · doi:10.1134/s2079086416060074 · Cited by 1
Retracted Article: FOXO4 overexpression suppresses hypoxia-induced-MCF-7 cell survival and promotes apoptosis through the HIF-2α/Bnip3 signal pathway
Qiao, Y., Wang, B., Zhang, H., Yan, Y., & Niu, L. (2019) · RSC Advances · doi:10.1039/c9ra04380b · Cited by 1
Retracted
Prevalence of BRCA1/BRCA2 frequent mutations in the Pakistani breast cancer patients.
Shabana, S., Liaqat, Z., Maqsood, F., Akhtar, T., Nasir, M. F., Sarwar, S., & Fatima, W. (2020) · The Professional Medical Journal · doi:10.29309/tpmj/2020.27.06.3701 · Cited by 1
Radioprotection Issues for Women with Hereditary Predisposition for Breast Cancer
Colin, C., Foray, N., & Bourguignon, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-41207-4_12 · Cited by 1
Breast and Gynecologic Tumors
Zhang, H., & Hicks, D. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-73227-1_5 · Cited by 1
Complex Genetic Systems and Diseases
Sarkar, S. (2012) · Wiley eBooks · doi:10.1002/9780470015902.a0005887.pub2 · Cited by 1
Microarray Bioinformatics and Applications in Oncology
Peeters, J. K. (2008) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 1
Dissecting the Heterogeneity of Breast Cancer*
Dubsky, P. C., & Jakesz, R. (2007) · Breast Care · doi:10.1159/000103242 · Cited by 1
Identification of Causal Rare Variants in an Extended Pedigree with Obsessive-compulsive Disorder
Rajendram, R. (2014) · TSpace (University of Toronto) · Cited by 1
Rare coding variants in GWAS identified loci with breast cancer risk
Han, M.-R. (2016) · Cited by 1
Young Women With Breast Cancer in Brazil: A Population‐Based Study Epidemiology of Breast Cancer in Young WomenPreprint
do Monte, R. L., da Silva, T. L., Santos, Y. H. D. S., Navarro, D. T. S. M., de Oliveira, T. C. A., & Lajus, T. B. P. (2021) · Research Square · doi:10.21203/rs.3.rs-145218/v1 · Cited by 1
Breast Cancer Susceptibility Genes
Deniz, M., & Wiesmüller, L. (2014) · Springer eBooks · doi:10.1007/978-3-642-27841-9_6619-3 · Cited by 1
Análise do complexo gênico FANCD2/FANCI em mulheres brasileiras com câncer de mama herediitário
Amstalden, L. G. (2011) · doi:10.47749/t/unicamp.2011.785911
Estudo dos genes NDRG1, Par-4, osteonectina e pontina, em tecido mamário hiperplásico através de técnica de imunohistoquímica
Barboza, R. F. (2011) · doi:10.11606/t.5.2011.tde-04082011-133848
Implications of BRCA1 mutations in basal-like breast cancer development and treatment
Gu, Y. (2015) · Työväentutkimus Vuosikirja
Xenopus laevis as a model system for evaluating the function of fanconi anemia proteins
Stone, S. (2008) · Pure Amsterdam UMC
Rastreo de SNPs en genes asociados a cáncer de mama en pacientes del noreste de México
Montelongo, M., & Nadezda, I. (2012) · Americanae (AECID Library)
Chromosomal alterations and telomere dysfunction in breast tumours
Böðvarsdóttir, S. K. (2008) · Skemman
Importancia de la ruta de Mek5/ErK5 en cáncer de mama
Ruíz, M. J. O. (2011) · doi:10.14201/gredos.110551
A Genetic Basis for Luminal and Basal-Type Breast Cancer
Hollestelle, A. (2009) · RePub (Erasmus University Rotterdam)
Network Medicine: Disease Genes in Molecular Networks
Chavali, S., & Kanduri, K. (2013) · Wiley eBooks · doi:10.1002/9783527665471.ch8
CHEK2 1100delC and polygenic susceptibility to breast cancer and colorectal cancer
Wasielewski, M. (2009) · RePub (Erasmus University Rotterdam)
The role of genetic factors in breast cancer aetiology
Hammond, V. (2010) · ePrints Soton (University of Southampton)
Identification and Management of Women at High Familial Risk for Breast Cancer
Kurian, A. W., & Ford, J. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6076-4_13
Growth factor endocrine pathway crosstalk : can treatment with trastuzumab activate steroid signalling?
Solon, J. G. (2012) · Figshare · doi:10.25419/rcsi.10815665

Authors: Walsh, T., & King, M.-C.
Affiliations: University of Washington (US)
Corresponding author: Walsh, Tom
King, Mary-Claire
ORCID: Walsh, Tom
King, Mary-Claire
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2007-02
Volume: 11
Issue: 2
Pages: 103-105
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/j.ccr.2007.01.010
OpenAlex: W2023353541
Cited by: 477
References: 15
Citations by year: 2026: 3 · 2025: 6 · 2024: 5 · 2023: 9 · 2022: 10 · 2021: 12 · 2020: 21 · 2019: 21 · 2018: 22 · 2017: 20 · 2016: 23 · 2015: 24 · 2014: 38 · 2013: 36 · 2012: 36
FWCI: 25.35
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 2358 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Keywords: hereditary breast cancer, germline mutations, BRCA1, BRCA2, p53, PTEN, CHEK2, ATM, NBS1, RAD50, BRIP1, PALB2, Fanconi anemia, genome stability, cancer susceptibility genes, ovarian cancer
MeSH terms: Fanconi Anemia Complementation Group N Protein, Breast Neoplasms, DNA-Binding Proteins, Fanconi Anemia, Humans, Neoplasm Proteins, Nuclear Proteins, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Acid Anhydride Hydrolases, Germ-Line Mutation, Cell Cycle Proteins, BRCA1 Protein, Genetic Predisposition to Disease, RNA Helicases, BRCA2 Protein, Tumor Suppressor Proteins, DNA Repair Enzymes, PTEN Phosphohydrolase, Fanconi Anemia Complementation Group Proteins, Ataxia Telangiectasia Mutated Proteins, Checkpoint Kinase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Ten Genes for Inherited Breast Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks